Filing Details
- Accession Number:
- 0001883850-24-000045
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-08-29 16:27:40
- Reporting Period:
- 2024-08-28
- Accepted Time:
- 2024-08-29 16:27:40
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 872589 | Regeneron Pharmaceuticals Inc. | REGN | Pharmaceutical Preparations (2834) | 133444607 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1697422 | R. Christopher Fenimore | 777 Old Saw Mill River Road Tarrytown NY 10591 | Svp Finance & Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2024-08-28 | 228 | $1,204.79 | 966 | No | 4 | S | Indirect | 2021 GRAT |
| Common Stock | Disposition | 2024-08-28 | 766 | $1,205.44 | 200 | No | 4 | S | Indirect | 2021 GRAT |
| Common Stock | Disposition | 2024-08-28 | 200 | $1,206.30 | 0 | No | 4 | S | Indirect | 2021 GRAT |
| Common Stock | Disposition | 2024-08-28 | 2,237 | $1,204.71 | 1,378 | No | 4 | S | Indirect | 2022 GRAT |
| Common Stock | Disposition | 2024-08-28 | 928 | $1,205.49 | 450 | No | 4 | S | Indirect | 2022 GRAT |
| Common Stock | Disposition | 2024-08-28 | 450 | $1,206.15 | 0 | No | 4 | S | Indirect | 2022 GRAT |
| Common Stock | Disposition | 2024-08-28 | 236 | $1,205.67 | 225 | No | 4 | S | Indirect | by Trust for Daugh |
| Common Stock | Disposition | 2024-08-28 | 200 | $1,206.70 | 25 | No | 4 | S | Indirect | by Trust for Daugh |
| Common Stock | Disposition | 2024-08-28 | 235 | $1,205.67 | 225 | No | 4 | S | Indirect | by Trust for Son |
| Common Stock | Disposition | 2024-08-28 | 200 | $1,206.67 | 25 | No | 4 | S | Indirect | by Trust for Son |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | 2021 GRAT |
| No | 4 | S | Indirect | 2021 GRAT |
| No | 4 | S | Indirect | 2021 GRAT |
| No | 4 | S | Indirect | 2022 GRAT |
| No | 4 | S | Indirect | 2022 GRAT |
| No | 4 | S | Indirect | 2022 GRAT |
| No | 4 | S | Indirect | by Trust for Daugh |
| No | 4 | S | Indirect | by Trust for Daugh |
| No | 4 | S | Indirect | by Trust for Son |
| No | 4 | S | Indirect | by Trust for Son |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 15,305 | Direct | |
| Common Stock | 1,515 | Indirect | By 401(k) Plan |
| Common Stock | 1,897 | Indirect | By Trust |
Footnotes
- Represents volume-weighted average price of sales of 228 shares of Company stock on August 28, 2024 at prices ranging from $1,204.76 to $1,204.83. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 28, 2024 at each separate price.
- Represents volume-weighted average price of sales of 766 shares of Company stock on August 28, 2024 at prices ranging from $1,205.02 to $1,205.78. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 28, 2024 at each separate price.
- Represents volume-weighted average price of sales of 200 shares of Company stock on August 28, 2024 at prices ranging from $1,206.09 to $1,206.63. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 28, 2024 at each separate price.
- Represents volume-weighted average price of sales of 2,237 shares of Company stock on August 28, 2024 at prices ranging from $1,204.00 to $1,204.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 28, 2024 at each separate price.
- Represents volume-weighted average price of sales of 928 shares of Company stock on August 28, 2024 at prices ranging from $1,205.00 to $1,205.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 28, 2024 at each separate price.
- Represents volume-weighted average price of sales of 450 shares of Company stock on August 28, 2024 at prices ranging from $1,206.00 to $1,206.66. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 28, 2024 at each separate price.
- Represents volume-weighted average price of sales of 236 shares of Company stock on August 28, 2024 at prices ranging from $1,205.51 to $1,205.78. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 28, 2024 at each separate price.
- Represents volume-weighted average price of sales of 200 shares of Company stock on August 28, 2024 at prices ranging from $1,206.66 to $1,206.86. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 28, 2024 at each separate price.
- Represents volume-weighted average price of sales of 235 shares of Company stock on August 28, 2024 at prices ranging from $1,205.51 to $1,205.78. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 28, 2024 at each separate price.
- Represents volume-weighted average price of sales of 200 shares of Company stock on August 28, 2024 at prices ranging from $1,206.65 to $1,206.68. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 28, 2024 at each separate price.
- These shares are held in a trust for the benefit of the reporting person's spouse. The reporting person and the reporting person's spouse are trustees of the trust.
Billionaire Hedge Funds
